Tue, March 20, 2012
[ Tue, Mar 20th 2012 ]: Market Wire
NuPathe Announces Fourth Quarter 2011 Financial Results and Operational Highlights
[ Tue, Mar 20th 2012 ]: Market Wire
PROLOR Biotech Initiates Phase II Trial of its Lo .. ormone in Children with Growth Hormone Deficiency
[ Tue, Mar 20th 2012 ]: Market Wire
AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2011 Financial Results
[ Tue, Mar 20th 2012 ]: Market Wire
Aeterna Zentaris to Announce Fourth Quarter and F .. Financial and Operating Results on March 27, 2012
[ Tue, Mar 20th 2012 ]: Market Wire
Mylan One of First to Launch Generic Version of Boniva
[ Tue, Mar 20th 2012 ]: Market Wire
NovaBay Set for "Phenomenal Year" With Key Upcomi .. l Data Announcements and Partnership Developments
[ Tue, Mar 20th 2012 ]: Market Wire
Covidien Announces FDA 510(k) Clearance of Nellcora" Respiration Rate Software
[ Tue, Mar 20th 2012 ]: Market Wire
Covidien annuncia approvazione FDA 510(k) del software Nellcora" Respiration Rate
[ Tue, Mar 20th 2012 ]: Market Wire
Covidien gibt FDA-510(k)-Zulassung der Nellcora" Respiration Rate Software bekannt
[ Tue, Mar 20th 2012 ]: Market Wire
Bioline Celebrates 20 Years of Service to Life Science
[ Tue, Mar 20th 2012 ]: Market Wire
Covidien annonce l'approbation 510(k) de la FDA r .. urveillance de la frquence respiratoire Nellcora"
[ Tue, Mar 20th 2012 ]: Market Wire
Enzo Biochem Announces Expanded Distribution Agreement with Japanas Cosmo Bio
[ Tue, Mar 20th 2012 ]: Market Wire
LCA-Vision to Present at the Maxim Group Growth Conference
[ Tue, Mar 20th 2012 ]: Market Wire
Pacira Pharmaceuticals, Inc. Announces Timing for .. 011 Financial Results Webcast and Conference Call
[ Tue, Mar 20th 2012 ]: Market Wire
Delcath Announces First Commercial CHEMOSAT Order in Europe
[ Tue, Mar 20th 2012 ]: Market Wire
Heptares Grants Shire an Exclusive Worldwide Lice .. mercialise Novel Drug Candidate for CNS Disorders
Mon, March 19, 2012
[ Mon, Mar 19th 2012 ]: Market Wire
OPKO Health Expands Collaboration with Arctic Partners
[ Mon, Mar 19th 2012 ]: Market Wire
Political Activist Filmmaker Kevin Booth Retained .. by Cannabis Science to Film Specialty Documentary
[ Mon, Mar 19th 2012 ]: Market Wire
MabCure Announces Agreement with the City Univers .. vanced Technology to Validate and Evaluate Its Mo
[ Mon, Mar 19th 2012 ]: Market Wire
Amarantus BioSciences Reports Addition of New Scientific Articles to MANF Publications List
[ Mon, Mar 19th 2012 ]: Market Wire
MMRGlobal Plans on Announcing Increased Revenues on March 30
[ Mon, Mar 19th 2012 ]: Market Wire
Rosetta Genomics to Present Multiple Poster Prese .. Meeting of the United States and Canadian Academy
[ Mon, Mar 19th 2012 ]: Market Wire
Stellar to Hold Conference Call re Health Canada .. of CAMBIA(R) for the Treatment of Acute Migraines
[ Mon, Mar 19th 2012 ]: Market Wire
Life Technologies Launches GeneArt Precision TALs
[ Mon, Mar 19th 2012 ]: Market Wire
Solta Medical to Present at Upcoming Investor Conferences
[ Mon, Mar 19th 2012 ]: Market Wire
Covidien annonce la signature daun accord dfinitif en vue de laacquisition de superDimension, Ltd.
[ Mon, Mar 19th 2012 ]: Market Wire
Covidien anuncia acordo final para adquirir a superDimension, Ltd.
[ Mon, Mar 19th 2012 ]: Market Wire
New Study Finds Cambridge Heartas MTWA Test to Be a Powerful Predictor of Sudden Cardiac Arrest
[ Mon, Mar 19th 2012 ]: Market Wire
Implant Sciences Appoints Dr. Bill McGann as Chief Operating Officer
[ Mon, Mar 19th 2012 ]: Market Wire
Covidien Announces Definitive Agreement to Acquire superDimension, Ltd.
[ Mon, Mar 19th 2012 ]: Market Wire
Covidien annuncia accordo definitivo per acquisire superDimension, Ltd.
[ Mon, Mar 19th 2012 ]: Market Wire
Delcath Announces Agreement with Instituto Oncologico Baselga for Launch of CHEMOSAT in Spain
[ Mon, Mar 19th 2012 ]: Market Wire
Illumina Files Definitive Proxy Materials and Sends Letter to Stockholders
[ Mon, Mar 19th 2012 ]: Market Wire
Co-Principal Investigator for OncoSec's Phase II .. o Speak at 70th Annual American Academy of Dermat
[ Mon, Mar 19th 2012 ]: Market Wire
Cytori Breast Reconstruction Cell Therapy Trial Results Published
Sun, March 18, 2012
[ Sun, Mar 18th 2012 ]: Market Wire
STATS ChipPAC Provides Updated Outlook for First Quarter 2012
Fri, March 16, 2012
[ Fri, Mar 16th 2012 ]: Market Wire
Kensey Nash Announces Mediated Settlement With St .. License Disputes and 5 Year Extension and Expansi
[ Fri, Mar 16th 2012 ]: Market Wire
Cubist Opens Expanded Research and Development Facility
[ Fri, Mar 16th 2012 ]: Market Wire
The Law Firm of Levi &;; Korsinsky Noti .. Their Investment in Columbia Laboratories Inc. o
[ Fri, Mar 16th 2012 ]: Market Wire
HeartWare Receives 54-Patient Allotment From FDA .. ol for Pivotal U.S. Bridge-to-Transplant Clinical
[ Fri, Mar 16th 2012 ]: Market Wire
Health Canada Approves CAMBIA(R) for the Treatment of Acute Migraine
[ Fri, Mar 16th 2012 ]: Market Wire
OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering
[ Fri, Mar 16th 2012 ]: Market Wire
HCA Named to Ethisphereas 2012 aWorldas Most Ethical Companiesa
[ Fri, Mar 16th 2012 ]: Market Wire
Cynosure to Present at 2012 Maxim Group Growth Conference
[ Fri, Mar 16th 2012 ]: Market Wire
Analytical Reports on Teva Pharmaceutical Industr .. tories Inc. - Drug Manufacturers Flexing Pipeline
[ Fri, Mar 16th 2012 ]: Market Wire
Equity Research on Unitedhealth Group Inc. and CIGNA Corp. - Health Care and the Economic Recovery
[ Fri, Mar 16th 2012 ]: Market Wire
ImmunoCellular Appoints Dr. Richard Chin To Board of Directors
[ Fri, Mar 16th 2012 ]: Market Wire
FDA Grants Cytori 510(k) Clearance for Puregraft(R) 850
[ Fri, Mar 16th 2012 ]: Market Wire
Echo Therapeutics, Inc. Announces 2011 Financial Results
[ Fri, Mar 16th 2012 ]: Market Wire
Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery
[ Fri, Mar 16th 2012 ]: Market Wire
American Oriental Bioengineering Inc. Announces D .. Filing of its Annual Report on Form 10-K for 2011
[ Fri, Mar 16th 2012 ]: Market Wire
Threshold Pharmaceuticals' TH-302 Receives Orphan .. pean Union for the Treatment of Soft Tissue Sarco
[ Fri, Mar 16th 2012 ]: Market Wire
Cambridge Heart Announces Microvolt T-Wave Alternans Receives Reimbursement Coverage in Japan
[ Fri, Mar 16th 2012 ]: Market Wire
Repligen Reports Financial Results for the Quarte .. nd Nine-Month Fiscal Year Ended December 31, 2011
[ Fri, Mar 16th 2012 ]: Market Wire
First Patient Enrolled Into European Registry for .. Stimulation in Patients With Refractory Epilepsy
Thu, March 15, 2012
[ Thu, Mar 15th 2012 ]: Market Wire
Genomma Lab Internacional to Nominate Slate of Fi .. Election at Prestige Brandsa 2012 Annual Meeting
[ Thu, Mar 15th 2012 ]: Market Wire
Anthera Provides Corporate Update on Recent Activities
[ Thu, Mar 15th 2012 ]: Market Wire
AdCare Health Systems Acquires Two Skilled Nursing Facilities in Oklahoma
[ Thu, Mar 15th 2012 ]: Market Wire
Leisureworld Announces March Dividend
[ Thu, Mar 15th 2012 ]: Market Wire
Verisante Technology, Inc. Announces Exclusive Di .. Agreement With Clarion Medical Technologies Inc.
[ Thu, Mar 15th 2012 ]: Market Wire
MethylGene Reports Fourth Quarter and Full Year 2011 Financial Results
[ Thu, Mar 15th 2012 ]: Market Wire
Amgen Announces 2012 Second Quarter Dividend
[ Thu, Mar 15th 2012 ]: Market Wire
Cytomedix Announces Publication in American Heart .. e Phase I Clinical Data Using ALD-201 to Treat Is
[ Thu, Mar 15th 2012 ]: Market Wire
Cynosure Introduces Enhanced Elite+ and Apogee+ Workstations for Faster Aesthetic Treatments
[ Thu, Mar 15th 2012 ]: Market Wire
Celsion Reports Year End 2011 Financial Results and Provides Business Update
[ Thu, Mar 15th 2012 ]: Market Wire
GenVec Reports Fourth Quarter and 2011 Year-End Financial Results
[ Thu, Mar 15th 2012 ]: Market Wire
Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
[ Thu, Mar 15th 2012 ]: Market Wire
United Therapeutics Files Lawsuit Against Sandoz for Infringement of Remodulin Patents
[ Thu, Mar 15th 2012 ]: Market Wire
Amedisys Scores 19% Above National Average on Treatment Goals Met at Home
[ Thu, Mar 15th 2012 ]: Market Wire
DaVita Clinics Give $67,000 to Ohio Charities
[ Thu, Mar 15th 2012 ]: Market Wire
Delcath Announces Agreement With Institut Gustave .. nch of Hepatic CHEMOSAT Delivery System in France
[ Thu, Mar 15th 2012 ]: Market Wire
InVivo Therapeutics Reports 2011 Financial Results, Provides Business Update
[ Thu, Mar 15th 2012 ]: Market Wire
Abbott Announces Patient Enrollment in Two Phase .. ab) for Moderate to Severe Hidradenitis Suppurati
[ Thu, Mar 15th 2012 ]: Market Wire
PAREXEL Global Survey Results Identify Top Concer .. iopharma Industry in Achieving Commercial Success
Wed, March 14, 2012
[ Wed, Mar 14th 2012 ]: Market Wire
Flamel Technologies Announces Acquisition of clat Pharmaceuticals
[ Wed, Mar 14th 2012 ]: Market Wire
Teva Announces Launch of Generic Lexapro in the U .. ; Awarded 180-Day Period of Marketing Exclusivity
[ Wed, Mar 14th 2012 ]: Market Wire
Guided Therapeutics to Report Q4 2011 Results and Hold Conference Call
[ Wed, Mar 14th 2012 ]: Market Wire
Securities Lawyers Seeking More Money, Informatio .. es Stockholders in Buyout, Announces Goldfarb LLP
[ Wed, Mar 14th 2012 ]: Market Wire
Goldfarb LLP Securities Lawyers Seek More Money, .. formation for Shareholders in Zoll Medical Buyout
[ Wed, Mar 14th 2012 ]: Market Wire
Biogen Idec Takes Option to MAKScientific MS Program
[ Wed, Mar 14th 2012 ]: Market Wire
Generex Subsidiary Antigen Express Announces Publ .. its Proprietary Therapeutic Vaccine Technology in
[ Wed, Mar 14th 2012 ]: Market Wire
Threshold Pharmaceuticals Doses First Patient in .. nical Trial Evaluating TH-302 in Multiple Myeloma
[ Wed, Mar 14th 2012 ]: Market Wire
Trimel Pharmaceuticals Corporation Provides Update on Operational Leadership
[ Wed, Mar 14th 2012 ]: Market Wire
Verastem, Inc. Reports Year-End 2011 Financial Results
[ Wed, Mar 14th 2012 ]: Market Wire
Covidien meldt resultaten van 2012 jaarlijkse algemene vergadering
[ Wed, Mar 14th 2012 ]: Market Wire
DaVita Thanks its 1,500 Dietitianson Registered Dietitian Day
[ Wed, Mar 14th 2012 ]: Market Wire
Federal Court Grants Request by BioDelivery Sciences for Stay of MonoSol Litigation
[ Wed, Mar 14th 2012 ]: Market Wire
Alnylam Retains Key Claims for Kinesin Spindle Pr .. ein (KSP) RNAi Patent in Interference Proceedings
[ Wed, Mar 14th 2012 ]: Market Wire
Synthetic Biologics Announces Completion of Enrol .. l Trial of Oral Trimestaa" for Multiple Sclerosis
[ Wed, Mar 14th 2012 ]: Market Wire
Marina Biotech and ProNAi Therapeutics Announce L .. nt for the Development of DNAi-Based Therapeutics
[ Wed, Mar 14th 2012 ]: Market Wire
OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial
[ Wed, Mar 14th 2012 ]: Market Wire
Sunshine Heart Announces FDA Completes Review of C-Pulse(R) Feasibility Data
[ Wed, Mar 14th 2012 ]: Market Wire
Perceptive Informatics Global Survey Results Show .. ption of Web-based RTSM Systems by Clinical Sites
Tue, March 13, 2012
[ Tue, Mar 13th 2012 ]: Market Wire
Kensey Nash Corporation Declares a Quarterly Dividend of $0.25 Per Share
[ Tue, Mar 13th 2012 ]: Market Wire
ActiveCare Acquires 4G Biometrics in Move to Addr .. ing Needs of Diabetic Patients and Their Families
[ Tue, Mar 13th 2012 ]: Market Wire
SciClone Reports Financial Results for the Fourth Quarter and Year 2011 and Outlook for 2012
[ Tue, Mar 13th 2012 ]: Market Wire
VELscope Vx(R) Approved for Use by AppleWhite Dental Partners
[ Tue, Mar 13th 2012 ]: Market Wire
Alkermes plc Completes Secondary Offering of 24,150,000 Ordinary Shares Held by Elan
[ Tue, Mar 13th 2012 ]: Market Wire
Endo Files Amended Citizen Petition Seeking Publi .. Safety and Efficacy Issues Prior to Approval of a
[ Tue, Mar 13th 2012 ]: Market Wire
NuPathe to Report Fourth Quarter and Full Year 20 .. d Hold Conference Call on Tuesday, March 20, 2012
[ Tue, Mar 13th 2012 ]: Market Wire
Comprehensive Care Corporation Celebrates 43rd Anniversary
[ Tue, Mar 13th 2012 ]: Market Wire
Enzo Biochemas Clinical Laboratory Applies for NY .. oval for First Assay Based on Its AmpiProbea" Amp
[ Tue, Mar 13th 2012 ]: Market Wire
Codexis to Present at Sidotias Emerging Growth Institutional Investor Forum
[ Tue, Mar 13th 2012 ]: Market Wire
Columbia Laboratories Hires Cowen and Company to .. st in Evaluating Potential Strategic Transactions
[ Tue, Mar 13th 2012 ]: Market Wire
OncoSec President and CEO Contributes to Today's Medical Developments
[ Tue, Mar 13th 2012 ]: Market Wire
Aeolus to Present at Roth Capital Partners' 24th Annual Growth Stock Conference
[ Tue, Mar 13th 2012 ]: Market Wire
Boston Scientific vor der bernahme von Cameron Health, Inc.
[ Tue, Mar 13th 2012 ]: Market Wire
Boston Scientific comprar Cameron Health, Inc.
[ Tue, Mar 13th 2012 ]: Market Wire
Acquisition de Cameron Health, Inc. par Boston Scientific
[ Tue, Mar 13th 2012 ]: Market Wire
Boston Scientific annuncia l'acquisizione di Cameron Health, Inc.
[ Tue, Mar 13th 2012 ]: Market Wire
Inovio Pharmaceuticals' PENNVAX-B HIV Vaccine Dem .. ell Immune Responses in Therapeutic Vaccine Trial
[ Tue, Mar 13th 2012 ]: Market Wire
AstraZeneca Files Lawsuit against the FDA for Dec .. rding Quetiapine Product Labeling and Exclusivity
Mon, March 12, 2012
[ Mon, Mar 12th 2012 ]: Market Wire
Cannabis Science Confirms Target Indication for F .. eeting with the FDA with Its Team of FDA Speciali
[ Mon, Mar 12th 2012 ]: Market Wire
Syneron to Acquire Assets of TransPharma Medical Ltd.
[ Mon, Mar 12th 2012 ]: Market Wire
Lpath Prepares to Continue iSONEP Trials in August
[ Mon, Mar 12th 2012 ]: Market Wire
Pfizer and Bristol-Myers Squibb Look to Reshape Anticoagulant Market
[ Mon, Mar 12th 2012 ]: Market Wire
Equity Research on Mylan Inc. and Watson Pharmace .. Makers Continue to Capitalize on Expiring Patents
[ Mon, Mar 12th 2012 ]: Market Wire
American Medical Association Adopts New Category III CPT Codes for Vagus Nerve Blocking Therapy
[ Mon, Mar 12th 2012 ]: Market Wire
Enzon Reports Fourth-Quarter and Full-Year 2011 Results
[ Mon, Mar 12th 2012 ]: Market Wire
WaferGen Appoints Ivan Trifunovich President, CEO, and Director
[ Mon, Mar 12th 2012 ]: Market Wire
Infinity Appoints Two Experienced Industry Leaders to Its Board of Directors
[ Mon, Mar 12th 2012 ]: Market Wire
Zynex Acquires NeuroDyne Medical, Corp.
[ Mon, Mar 12th 2012 ]: Market Wire
International Stem Cell Corporation Completes $5 .. and Elects Jim Berglund to the Board of Directors
[ Mon, Mar 12th 2012 ]: Market Wire
ImmunoCellular Therapeutics Reports Manufacturing Process Data for ICT-107
[ Mon, Mar 12th 2012 ]: Market Wire
Threshold Pharmaceuticals' TH-302 to Be Featured .. Cancer Hosted by the New York Academy of Sciences
[ Mon, Mar 12th 2012 ]: Market Wire
ONSOLIS Relaunch Postponed Pending Product Modification
[ Mon, Mar 12th 2012 ]: Market Wire
Given Imaging Announces Publication of Colon Capsule Endoscopy Guidelines in Endoscopy
[ Mon, Mar 12th 2012 ]: Market Wire
Teleflex Appoints Thomas E. Powell Senior Vice President & Chief Financial Officer
[ Mon, Mar 12th 2012 ]: Market Wire
PAREXEL Experts to Address Approaches to Accelera .. ase Development Decisions at ASCPT Annual Meeting
[ Mon, Mar 12th 2012 ]: Market Wire
Medisafe 1 Technologies Signs Marketing and Distribution Agreement with Health Product Carrier
[ Mon, Mar 12th 2012 ]: Market Wire
Sunshine Heart Provides FAQ Regarding Transmutation of CDIs to Common Stock
Sat, March 10, 2012
[ Sat, Mar 10th 2012 ]: Market Wire
Gegevens tonen aan dat Gilead';;s .. ferieur is aan op protease gebaseerd regime na 48
[ Sat, Mar 10th 2012 ]: Market Wire
I dati di un secondo importante studio di Fase II .. t del regime Quad di Gilead per il trattamento de
[ Sat, Mar 10th 2012 ]: Market Wire
Quad-HIV-Prparat von Gilead nach 48 Wochen nicht .. g auf Protease-Basis: Beleg durch Daten einer zwe
[ Sat, Mar 10th 2012 ]: Market Wire
Los datos muestran que el rgimen Quad de Gilead p .. rgimen basado en proteasa a las 48 semanas en un
[ Sat, Mar 10th 2012 ]: Market Wire
Gegevens tonen aan dat Gilead's Quad-regime voor .. protease gebaseerd regime na 48 weken, in tweede
[ Sat, Mar 10th 2012 ]: Market Wire
Tenet to Speak at the Barclays Capital Healthcare Conference on March 14th
[ Sat, Mar 10th 2012 ]: Market Wire
Glancy Binkow & Goldberg LLP Announces Lead Plain .. e In The Class Action Lawsuit Against TranS1 Inc.
Fri, March 9, 2012
[ Fri, Mar 09th 2012 ]: Market Wire
Edwards Lifesciences to Present at the 24th Annual ROTH Conference
[ Fri, Mar 09th 2012 ]: Market Wire
Patient Home Monitoring (PHM) Announces February .. s and Growth Figures, Change in Operation Executi
[ Fri, Mar 09th 2012 ]: Market Wire
The Law Firm of Levi amp;; Korsinsky, LLP .. anscend Services, Inc. in Connection with the Sal
[ Fri, Mar 09th 2012 ]: Market Wire
Titan Medical Inc. Files Prospectus Supplement for Unit Offering
[ Fri, Mar 09th 2012 ]: Market Wire
Regeneron Announces Change in Date for Presentati .. arclays Capital 2012 Global Healthcare Conference
[ Fri, Mar 09th 2012 ]: Market Wire
Is Health Discovery Corporation Finally on the Verge of a Turnaround?
[ Fri, Mar 09th 2012 ]: Market Wire
Sequenom, Genworth Financial, Huntsman, New Gold, Huntington Bancshares, and Amarin
[ Fri, Mar 09th 2012 ]: Market Wire
Cantel Medical Corp. to Present at the Sidoti amp .. nth Annual Emerging Growth Institutional Investor
[ Fri, Mar 09th 2012 ]: Market Wire
(NYSE Amex: DXR) Daxor Announces Filing of Two Ad .. onal Patents for Updated Automated Blood Analyzer
[ Fri, Mar 09th 2012 ]: Market Wire
Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on PhotoMedex, Inc.
[ Fri, Mar 09th 2012 ]: Market Wire
Ardea Biosciences Reports Recent Accomplishments .. urth Quarter and Full-Year 2011 Financial Results
[ Fri, Mar 09th 2012 ]: Market Wire
BD to Present at the Barclays Capital Global Healthcare Conference
[ Fri, Mar 09th 2012 ]: Market Wire
Equity Research on Valeant Pharmaceuticals Intern .. n Corp. plc - Drug Delivery Companies Up and Down
[ Fri, Mar 09th 2012 ]: Market Wire
Peregrine Reports Data From Phase II Front-Line Lung Cancer Trial
[ Fri, Mar 09th 2012 ]: Market Wire
Haemonetics Sets Date for Investor/Analyst Meeting
[ Fri, Mar 09th 2012 ]: Market Wire
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2011 Financial Results
[ Fri, Mar 09th 2012 ]: Market Wire
EntreMed Reports Fourth Quarter and Year-End 2011 Financial Results
[ Fri, Mar 09th 2012 ]: Market Wire
Halozyme Reports Fourth Quarter and Year End 2011 Financial Results and Provides Guidance for 2012
[ Fri, Mar 09th 2012 ]: Market Wire
Delcath Selects Quintiles to Support EU Launch of CHEMOSAT
Thu, March 8, 2012
[ Thu, Mar 08th 2012 ]: Market Wire
BIOLASE Chief Executive Officer to Continue at Rate of $1.00 Annual Salary
[ Thu, Mar 08th 2012 ]: Market Wire
PDL BioPharma Provides First Quarter 2012 Royalty Revenue Guidance of $77 Million
[ Thu, Mar 08th 2012 ]: Market Wire
OncoGenex Pharmaceuticals, Inc. Reports Financial .. and Year End 2011 and Provides Update on Clinical
[ Thu, Mar 08th 2012 ]: Market Wire
Sangamo Presents New Clinical Data at CROI 2012 D .. ive Effects of ZFN Therapeutic for "Functional Cu
[ Thu, Mar 08th 2012 ]: Market Wire
Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System Receives FDA Clearance
[ Thu, Mar 08th 2012 ]: Market Wire
LED Dental Launches Second Step Laboratory Services in Canada
[ Thu, Mar 08th 2012 ]: Market Wire
Amylin Pharmaceuticals Announces Pricing of Public Offering of Common Stock
[ Thu, Mar 08th 2012 ]: Market Wire
Boston Scientific Renews Agreement with Lumenis t .. ative Laser Products to Treat Urologic Conditions
[ Thu, Mar 08th 2012 ]: Market Wire
MIT Agrees to $3.2 Million in Financing, Includin .. in Convertible Debentures and $1.2 Million in Deb
[ Thu, Mar 08th 2012 ]: Market Wire
Celsion Corporation to Hold Year-End 2011 Financi .. sults Conference Call on Thursday, March 15, 2012
[ Thu, Mar 08th 2012 ]: Market Wire
Palatin Technologies Completes Enrollment in Phas .. 2B Bremelanotide Female Sexual Dysfunction Trial
[ Thu, Mar 08th 2012 ]: Market Wire
Michael E. DeBakey VA Medical Center Initiates Ph .. ia with Aeterna Zentaris' Ghrelin Agonist, AEZS-1
[ Thu, Mar 08th 2012 ]: Market Wire
Isis Pharmaceuticals to Present at the Barclays Capital 2012 Global Healthcare Conference
[ Thu, Mar 08th 2012 ]: Market Wire
Implant Sciences Sells More QS-H150 Explosives Trace Detection Devices to Chinese Airports
[ Thu, Mar 08th 2012 ]: Market Wire
OncoSec to Evaluate Potential Predictive or Progn .. t of Solid Tumor Cancers Using OMS ElectroImmunot
[ Thu, Mar 08th 2012 ]: Market Wire
Biodel Inc. to Present at ROTH 24th Annual OC Growth Stock Conference on March 14th, 2012
[ Thu, Mar 08th 2012 ]: Market Wire
Threshold Pharmaceuticals Reports Fourth Quarter .. d Year End 2011 Financial and Operational Results
[ Thu, Mar 08th 2012 ]: Market Wire
Sana Kliniken AG firma un acuerdo con Masimo para .. oluciones de supervisin de pacientes no invasivas
[ Thu, Mar 08th 2012 ]: Market Wire
Regeneron and Bayer Announce Approval of EYLEA (a .. Treatment of Wet Age-Related Macular Degeneratio
Wed, March 7, 2012
[ Wed, Mar 07th 2012 ]: Market Wire
Law Firm Brower Piven Announces Investigation in .. on of Transcend Services, Inc. by Nuance Communic
[ Wed, Mar 07th 2012 ]: Market Wire
Resmed Inc. to Present at Upcoming Conferences
[ Wed, Mar 07th 2012 ]: Market Wire
International Drug &;; Explosives Detec .. ounces Strategic Alliance With an American Compan
[ Wed, Mar 07th 2012 ]: Market Wire
SPX-106T Arrests Development of Atherosclerotic Plaques in Mouse Model of Cardiovascular Disease
[ Wed, Mar 07th 2012 ]: Market Wire
Fourteenth Patient Dosed in Neuralstem ALS Stem Cell Trial
[ Wed, Mar 07th 2012 ]: Market Wire
Prana Doses First Patient in the "IMAGINE" Phase II Alzheimer's Disease Trial
[ Wed, Mar 07th 2012 ]: Market Wire
EnteroMedics to Present at the 24th Annual ROTH Capital Growth Conference
[ Wed, Mar 07th 2012 ]: Market Wire
Discovery Labs to Hold Conference Call to Discuss FDA Approval of SURFAXIN (lucinactant)
[ Wed, Mar 07th 2012 ]: Market Wire
iBio to Present at the 24th Annual ROTH Conference on March 14
[ Wed, Mar 07th 2012 ]: Market Wire
Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference
[ Wed, Mar 07th 2012 ]: Market Wire
Synthetic Biologics to Present at ROTH Annual Growth Stock Conference
[ Wed, Mar 07th 2012 ]: Market Wire
Transcept Pharmaceuticals to Report Fourth Quarte .. l Results and Host Conference Call on March 14, 2
[ Wed, Mar 07th 2012 ]: Market Wire
Horizon Pharma Enters Into Exclusive Agreement Wi .. ization of LODOTRA(R) (Modified-Release Prednison
[ Wed, Mar 07th 2012 ]: Market Wire
CMS Assigns Payment to Novadaq's SPY Imaging Under OPPS
[ Wed, Mar 07th 2012 ]: Market Wire
Solta Medical Provides Update on Liposonix Launch
[ Wed, Mar 07th 2012 ]: Market Wire
The Ensign Group Acquires an Idaho Skilled Nursing Facility
[ Wed, Mar 07th 2012 ]: Market Wire
OncoSec's OMS ElectroImmunotherapy Technology Pla .. I Merkel Cell Carcinoma Clinical Trial Featured i
[ Wed, Mar 07th 2012 ]: Market Wire
Inovio Appoints Vaccine Industry Leader to its Scientific Advisory Board
Tue, March 6, 2012
[ Tue, Mar 06th 2012 ]: Market Wire
AcelRx Announces Initiation of Phase 3 Clinical P .. anil NanoTab PCA System for the Treatment of Post
[ Tue, Mar 06th 2012 ]: Market Wire
Columbia Laboratories Receives Nasdaq Minimum Bid Price Non-compliance Letter
[ Tue, Mar 06th 2012 ]: Market Wire
China Pharma Holdings, Inc. to Report Fiscal Year 2011 Financial Results on March 15, 2012
[ Tue, Mar 06th 2012 ]: Market Wire
Nordion Reports First Quarter 2012 Financial Results
[ Tue, Mar 06th 2012 ]: Market Wire
Discovery Labs Announces FDA Approval of SURFAXIN .. ) for Prevention of Respiratory Distress Syndrome
[ Tue, Mar 06th 2012 ]: Market Wire
Centene Corporation to Present at Barclays Capital 2012 Global Healthcare Conference

Codexis to Present at Sidotias Emerging Growth Institutional Investor Forum


  Copy link into your clipboard //health-fitness.news-articles.net/content/2012/ .. merging-growth-institutional-investor-forum.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

REDWOOD CITY, Calif.--([ ])--Codexis, Inc. (NASDAQ:CDXS), a developer of industrial enzymes to enable the production of biofuels, bio-based chemicals, and pharmaceutical intermediates, today announced that Peter Strumph, interim Chief Executive Officer, will be presenting at the Sidoti & Company 16th Annual Emerging Growth Institutional Investor Forum, to be held in New York, NY on Tuesday, March 20, 2012 at 2:40 p.m. ET. The conference will be held at The Grand Hyatt New York and a copy of the presentation will be available in the Investors section of [ www.codexis.com ]. A webcast for this presentation is not being provided at this conference.

About Codexis, Inc.

Codexis, Inc. is a developer of industrial enzymes to enable the production of biofuels, bio-based chemicals and pharmaceutical intermediates. Codexis' product lines include CodeXymea" Cellulase Enzymes and CodeXola" Detergent Alcohol. Partners and customers include global leaders such as Shell, Merck and Pfizer. For more information, see [ www.codexis.com ].


Publication Contributing Sources